Fundz

Remission Medical, a Richmond, VA-based virtual rheumatology company, closed a Series A funding round led by Blue Heron Capital to enhance its partner network and grow its clinical workforce.

PRIVATEApr 13, 2026

Round Type

Series A

BiotechnologyHealth CareMedical

Investors

Blue Heron Capital

Description

Remission Medical, Inc. raised an undisclosed amount in Series A funding. The round was led by Blue Heron Capital. The company intends to use the funds to further enhance the expansion of its partner network, grow its clinical workforce, and accelerate scaling infrastructure.

Quick answer

Remission Medical raised an undisclosed amount in a Series A round, dated April 13, 2026. Investors: Blue Heron Capital.

How much did Remission Medical raise?
Remission Medical raised an undisclosed amount in a Series A round on April 13, 2026.
Who invested in Remission Medical?
Blue Heron Capital is named as investors in this round.
What does Remission Medical do?
Remission Medical is a national virtual rheumatology platform developing solutions for conditions including rheumatoid arthritis, osteoporosis, osteoarthritis, lupus, and gout.
Where is Remission Medical based and how big is it?
Fundz records about 23 employees.
Who are the decision-makers at Remission Medical?
Fundz holds 2 contacts at Remission Medical, including the Founder & CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Remission Medical that raised within 45 days of this round, from Fundz verified event records.

  • Captive Radiology raised an undisclosed amount on May 27, 2026.
  • Adenocyte Ltd raised an undisclosed amount (Funding Round) on May 26, 2026.
  • Kordata Dynamics raised an undisclosed amount (Pre-Seed) on May 21, 2026.
  • Stride raised $15M (Funding Round) on May 21, 2026.
  • Vital Signals raised $15M (Seed) on May 19, 2026.
  • Garland Surgical Ltd raised $4.1M (Seed) on May 19, 2026.

Who to call at Remission Medical, and when

A new round usually means Remission Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Remission Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Remission Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Remission Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Remission Medical

About

Remission Medical is a national virtual rheumatology platform developing solutions for conditions including rheumatoid arthritis, osteoporosis, osteoarthritis, lupus, and gout. Its proprietary AI-native workforce platform, RemissionOS, is designed to manage a distributed clinical workforce across multiple health systems. The company focuses on automating processes such as referral intake and clinical scheduling to enhance operations. Remission Medical operates with major health system partners nationwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Remission Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsBlake W., Founder & CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Remission Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Remission Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.